Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Directorate Change

16 Jan 2019 07:00

RNS Number : 1910N
Wilmington PLC
16 January 2019
 

16 January 2019

Wilmington plc

("Wilmington" or the "Company" or "Group")

Directorate Change

 

Wilmington plc (LSE: WIL), the provider of information, education and networking services in Risk & Compliance, Professional and Healthcare knowledge areas, announces that Pedro Ros has informed the Board of his intention to step down from his position as Chief Executive Officer of the Company. The Board has agreed with Pedro that he will step down from the Board on 13 February 2019 and will be available over the following months to ensure a smooth and orderly handover.

 

Martin Morgan, Chairman, will act as Executive Chairman from 13 February until Pedro's replacement is appointed. The Board will initiate a search for a new Chief Executive Officer and an update will be made in due course.

 

As previously advised, the Company will announce its half year results for the period to 31 December 2018 on Thursday 21 February 2019.

 

Martin Morgan, Chairman, commented:

 

"I would like to thank Pedro for his dedication and contribution to Wilmington over the last five years. Since joining Wilmington in 2014, Pedro has executed a significant change programme and focused on building our key market sectors in Risk & Compliance, Professional and Healthcare. During Pedro's tenure, Wilmington has also begun the important process of modernising its infrastructure which includes the implementation of common technologies, especially in the areas of customer relationship management, digital learning and marketing. The Company has many opportunities for renewed growth and, on behalf of the Board and employees of Wilmington, we wish Pedro all the best in his future endeavours."

 

Pedro Ros, Chief Executive Officer, said: 

 

"During the last five years, Wilmington has completed a major transformation and I believe that now is the right time to hand over to my successor. I am proud of our many achievements during that time and I thank our people and the Board for their continuous support. I look forward to working with Martin to ensure a smooth transition."

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 592/2014. Upon the publication of this announcement via a Regulatory Information Service this inside information is now considered to be in the public domain.

 

For further information, please contact:

Wilmington plc

Martin Morgan, Chairman

Richard Amos, Chief Financial Officer

 

FTI Consulting

Charles Palmer / Dwight Burden / Leah Dudley

 

020 7490 0049

 

 

 

020 3727 1000

 

 

 

Notes to Editors

Wilmington is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Professional and Healthcare areas. Wilmington employs close to 1,000 people and operates in 120 countries. Wilmington plc is a premium listed company on the main market of the London Stock Exchange.

 

-End-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOACKPDDFBKDQDD
Date   Source Headline
27th Sep 20132:29 pmRNSShare Awards
19th Sep 20137:00 amRNSPreliminary Results
12th Sep 20132:24 pmRNSHolding(s) in Company
3rd Sep 201310:15 amRNSTotal Voting Rights
27th Aug 20133:57 pmRNSHolding(s) in Company
16th Aug 20137:00 amRNSAcquisition of Compliance Week
5th Aug 20133:22 pmRNSTotal Voting Rights
10th Jul 201311:04 amRNSHolding(s) in Company
1st Jul 20139:59 amRNSTotal Voting Rights
27th Jun 201312:41 pmRNSNotice of Results
4th Jun 20139:45 amRNSVoting Rights and Capital
16th May 20137:00 amRNSInterim Management Statement
10th May 20133:03 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st May 201310:16 amRNSTotal Voting Rights
3rd Apr 20134:18 pmRNSVoting Rights and Capital
26th Mar 201311:04 amRNSHolding(s) in Company
15th Mar 20134:40 pmRNSSecond Price Monitoring Extn
15th Mar 20134:37 pmRNSPrice Monitoring Extension
4th Mar 20137:00 amRNSAcquisition of Inese
1st Mar 201310:56 amRNSTotal Voting Rights
26th Feb 20137:00 amRNSInterim Results
7th Feb 20133:39 pmRNSAcquisition
6th Feb 201310:41 amRNSTotal Voting Rights
4th Jan 20133:00 pmRNSNotice of Results
2nd Jan 201311:31 amRNSVoting Rights and Capital
24th Dec 201211:12 amRNSProperty Sale
21st Dec 20127:00 amRNSSegmental Analysis
18th Dec 20124:40 pmRNSSecond Price Monitoring Extn
18th Dec 20124:35 pmRNSPrice Monitoring Extension
4th Dec 20129:08 amRNSTotal Voting Rights
22nd Nov 20124:45 pmRNSHolding(s) in Company
16th Nov 20123:05 pmRNSBlocklisting Interim Review
16th Nov 20123:00 pmRNSBoard Change
16th Nov 20127:00 amRNSCapital Markets Day
14th Nov 20124:00 pmRNSResult of AGM
14th Nov 20127:00 amRNSInterim Management Statement
13th Nov 20125:00 pmRNSHolding(s) in Company
2nd Nov 20121:28 pmRNSTotal Voting Rights
29th Oct 20122:19 pmRNSDirector/PDMR Shareholding
11th Oct 20124:20 pmRNSHolding(s) in Company
11th Oct 20122:32 pmRNSHolding(s) in Company
11th Oct 201210:06 amRNSDirector/PDMR Shareholding
10th Oct 20125:30 pmRNSTreasury Shares
2nd Oct 20122:45 pmRNSVoting Rights and Capital
18th Sep 20127:00 amRNSFinal Results
3rd Sep 20123:13 pmRNSVoting Rights and Capital
17th Aug 201212:10 pmRNSHolding(s) in Company
2nd Aug 201210:31 amRNSTotal Voting Rights
24th Jul 20124:37 pmRNSHolding(s) in Company
13th Jul 20124:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.